ArticleCancer research and treatment2024

Association of Immune-Related Adverse Events and the Efficacy of Anti-PD-(L)1 Monotherapy in Non-Small Cell Lung Cancer: Adjusting for Immortal-Time Bias.

Ying Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.